Pharma Clinical Trial Services Market and Industry Forecast 2017-2027

LONDON, July 26, 2017 /PRNewswire/ --

Early Phase Services, Late Phase Services, Other Services, Pharma, Biotech, Other End-Users, Cancer, Cardiovascular Diseases, CNS, Infectious Diseases, Metabolic Diseases, Other Diseases.

The pharma clinical trial services market is expected to grow at a CAGR of 9.5% in the first half of the forecast period. The market is expected to grow at a CAGR of 9.8% from 2016-2027. The pharma clinical trial services market is estimated at $39.56bn in 2016 dominated by the late-phase services, which held 56% of share.

     (Logo: http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg )

How this report will benefit you:

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 188-page report you will receive 145 charts - all unavailable elsewhere.

The 188-page report provides clear detailed insight into the pharma clinical trial services market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope: 

• Pharma Clinical Trial Services Market forecasts from 2017-2027.

• This report breaks down the revenue forecast for pharma clinical trial services market by type of service:
• Early Phase Services
• Late Phase Services
• Other Services

Each submarket is further divided by region: North America, Europe, Asia-Pacific and RoW.

• This report breaks down the revenue forecast for pharma clinical trial services market by End-Users:
• Pharma
• Biotech Companies
• Other End-Users

Each submarket is further divided by region: North America, Europe, Asia-Pacific and RoW.

• This report breaks down the revenue forecast for pharma clinical trial services market by Therapeutic Area:
• Cancer
• Cardiovascular
• CNS
• Infectious Diseases
• Metabolic Diseases
• Other Diseases

Each submarket is further divided by region: North America, Europe, Asia-Pacific and RoW.

• This report provides individual revenue forecasts to 2027 for these regional and national markets:
• North America: the US and Rest of North America
• Europe: France, Germany, the UK, Spain, Italy, Russia, Central and Eastern Europe, Rest of Europe
• Asia-Pacific: China, India, Japan, South Korea, Rest of APAC
• Rest of the World: Latin America, Middle East and Africa, Brazil

Each regional market is further divided by type of service, end-users and therapeutic area.

• Our study discusses factors that drive and restrain the pharma clinical trial services market. This report also provides a STEP analysis.

• This report discusses the leading companies in pharma clinical trial services market:
• Quintiles IMS Holdings Inc.
• LabCorp (Covance Inc.)
• Pharmaceutical Product Development (PPD), LLC
• Parexel International Corporation
• ICON
• INC Research
• inVentiv Health
• PRA Health Sciences
• Chiltern International
• Charles River Laboratories

Visiongain's study is intended for anyone requiring commercial analyses for the pharma clinical trial services market. You find data, trends and predictions.

Buy our report today Pharma Clinical Trial Services Market and Industry Forecast 2017-2027: Early Phase Services, Late Phase Services, Other Services, Pharma, Biotech, Other End-Users, Cancer, Cardiovascular Diseases, CNS, Infectious Diseases, Metabolic Diseases, Other Diseases.

To request a report overview of this report please email Sara Peerun at sara.peerun@visiongain.com or call Tel: +44-(0)-20-7336-6100

Or click on https://www.visiongain.com/Report/1931/Pharma-Clinical-Trial-Services-Market-and-Industry-Forecast-2017-2027

Companies Mentioned in the Report: 

3C Alliance

Actavis

Adamas Pharmaceuticals

Adheris (an InVentiv Health company)

Agilent Technologies

Agility Clinical

AKESOgen

Akos

Allscripts

Amgen

Aptiv Solutions (now part of ICON plc)

Aptuit

ASAN Medical Center

Assent Consulting

Astellas Pharma

Avista Capital Partners

Baxter International

Bayer

BeijingWits Medical Consulting (part of ICON)

Berry Consultants

BioBay

BioClinica

BioDuro (part of PPD)

BioDuro Biologics

Biogen Idec

Biomedical Systems

BioTrak

Bioxydyn

BML

Boehringer Ingelheim

Bridgepoint Development Capital

Bristol-Myers Squibb

Caprion

Catalent

Catalina Health (part of InVentiv Health)

Celerion

Charles River Laboratories

ClinForce

Clinical Trial Support

Clinigene International

Clinipace Worldwide

ClinStar

CMIC Holdings

CMIC (Beijing) Co

CNS Healthcare

CNS Vital Signs

Cogtest (part of The Cognition Group)

Corex Pharmaceutical

CRI Lifetree (part of PRA Health Sciences)

Cromos Pharma

CROMSOURCE

Cross Country Healthcare Inc

Czura Thornton

Dako (part of Agilent Technologies)

Duke Clinical Research Institute

EF Education First

Eisai

Ekam Imaging

Eli Lilly

EPS Corporation (now EPS Holdings, Inc.)

EPS Holdings, Inc.

Firecrest Clinical (part of ICON)

Forest Pharmaceuticals

Frontage Laboratories

GCP ClinPlus

GE Healthcare

Genstar Capital

Global CNS Research

Global Research Services (GRS)

Główny Urząd Statystyczny (Polish Central Statistical Office)

GSK

Harlan Laboratories (part of Huntingdon Life Sciences)

Hellman & Friedman

Hisun Pharmaceuticals

Huntingdon Life Sciences

i3 Research (part of inVentiv Health)

ICON

ImageIQ

ImmuneHealth

INC Research

Infociencia (part of RPS)

Inspire

Institute for Medical Research Management and Biometrics (IMEREM, part of RPS)

Integrium

inVentiv Health

J&J

Janssen Pharmaceuticals (a subsidiary of J&J)

Japan Pharmaceutical Manufacturers Association (JPMA)

Jasper Clinical Research and Development Inc.

Java Clinical

JCL Bioassay Corporation (part of CMIC Holdings)

Julphar

Kendle (part of INC Research)

Kester Capital

Kforce

Kforce Clinical Research (KCR, part of inVentiv Health)

Kinship Technologies (part of PRA Health Sciences)

KKR

Korea National Enterprise for Clinical Trials (KoNECT)

Kun Tuo (part of Quintiles)

Laboratory Corporation of America (LabCorp)

Les Entreprises du Médicament (LEEM)

LSK Global

MAB Discovery

Malaysian Biotechnology Corporation

Massachusetts General Hospital

Maximax Pharmaceutical Research

MDS Pharma Services (part of INC Research)

MedAvante

Medaxial

Medelis

Medicines and Healthcare products Regulatory Agency (MHRA) [UK]

Medidata Solutions

MediMedia Pharma Solutions (now part of ICON plc)

Medipal Holdings

Medivation

MEK Consulting (part of INC Research)

Merck & Co.

Merck BioVentures

Merck KGaA

Metabolon

MetricStream

Mitsubishi Gas Chemical Company, Inc.

Molecular NeuroImaging

MorphoSys

MPI Research

MRM Proteomics

Myriad Genetics

Mytrus

Nautic Partners

NeuroImage

NextGen Sciences

Nexus Oncology, an Ockham Company (formerly Nexus Oncology)

Novartis

Novotech

Ockham

OCT

Omnicare

Oncobiologics

Ontario Teachers' Pension Plan

Oxford Cancer Biomarkers

Oxford Gene Technology (OGT)

Oxford Outcomes (part of ICON)

Pacific Biomarkers

Paragon Biomedical (part of Clinipace Worldwide)

Paramax International (part of RPS)

Parexel International

PatientsLikeMe

Perceptive Informatics (part of Parexel)

PFC Pharma Focus (part of Clinipace Worldwide)

Pfizer

PharmaNet Development Group (part of inVentiv Health)

Pharmaron

PPD

PRA International

Prana Biotechnology

PriceSpective (part of ICON)

Prodia Clinical Laboratory

Proteome Sciences

ProTrials Research

PSR Orphan Experts

Psychmed (part of The Cognition Group)

QED Clinical Services

Quintiles

Quotient Clinical

RCT Logic

Regulus Pharmaceutical Consulting (part of Clinipace Worldwide)

ReSearch Pharmaceutical Services (RPS, part of PRA International)

Roche

Rules Based Medicine (now Myriad RBM, part of Myriad Genetics)

Samsung

SAS

ShangPharma

Shire

Syngene International

Sugi Medical Co (part of CMIC)

Taijitu Biologics

Targos Molecular Pathology

Tessella

The Carlyle Group

The Clinical Trial Company

The Cognition Group

Theorem Clinical Research

Theradex Systems

Therapharm Recherches (part of RPS)

Thomas H. Lee Partners

Tigermed Consulting

Timaq Medical Imaging (part of ICON)

Trident Clinical Research (part of INC Research)

UCB

University of Manchester

Veeda Clinical Research

Veeva Systems

Vigiun (part of Chiltern International)

VirtualScopics

Warburg Pincus

West Coast Clinical Trials (WCCT)

Worldwide Clinical Research

WuXi AppTec

WuXi PharmaTech

Yungjin Pharmaceutical

Zhejiang Jiang Yuan Tang Biotechnology Co., Ltd

To see a report overview please email Sara Peerun on sara.peerun@visiongain.com